United States · FDA National Drug Code directory
IBUPROFEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-321_5447b3da-b7bc-776b-e063-6394a90a1027
- Product NDC
- 62207-321
- Form
- TABLET
- Composition / generic term
- IBUPROFEN
- Labeler
- Granules India Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191114
- Source listing expiry
- 20271231
Source-listed ingredients
- IBUPROFEN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 24 TABLET in 1 BOTTLE (62207-321-41) · 62207-321-41
- 50 TABLET in 1 BOTTLE (62207-321-42) · 62207-321-42
- 100 TABLET in 1 BOTTLE (62207-321-43) · 62207-321-43
- 250 TABLET in 1 BOTTLE (62207-321-46) · 62207-321-46
- 500 TABLET in 1 BOTTLE (62207-321-47) · 62207-321-47
- 750 TABLET in 1 BOTTLE (62207-321-48) · 62207-321-48
- 1000 TABLET in 1 BOTTLE (62207-321-49) · 62207-321-49
- 10 TABLET in 1 BOTTLE (62207-321-89) · 62207-321-89
- 1700 TABLET in 1 BOTTLE (62207-321-90) · 62207-321-90
- 160000 TABLET in 1 DRUM (62207-321-91) · 62207-321-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →